Related Experiment Video
Updated: Jun 9, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Sublobar resection for early-stage lung cancer
Matthew J Schuchert1, Ghulam Abbas, Arjun Pennathur
1Division of Thoracic and Foregut Surgery, Heart, Lung, and Esophageal Surgery Institute, UPMC Health System, Pittsburgh, Pennsylvania, USA. schuchertmj@upmc.edu
Seminars in Thoracic and Cardiovascular Surgery
|September 4, 2010
Summary
Sublobar resection may be safe for small early-stage non-small cell lung cancers, especially in elderly or high-risk patients. Careful selection is key, as lobectomy remains preferred for larger tumors or when margins are insufficient.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Sublobar resection techniques (anatomic segmentectomy, extended wedge) for early-stage non-small cell lung cancer (NSCLC) historically show higher local recurrence than lobectomy.
- Emerging data suggest sublobar resection may be viable for smaller tumors (< or =2 cm) with comparable outcomes.
Purpose of the Study:
- To evaluate the safety and efficacy of sublobar resection versus lobectomy for early-stage non-small cell lung cancer.
- To identify patient and tumor characteristics that predict optimal surgical approach.
Main Methods:
- Review of recent data and ongoing prospective, randomized trials (CALGB 140503, ACOSOG Z4032).
- Focus on local recurrence rates, long-term survival, and patient selection criteria.
Main Results:
- Sublobar resection of smaller tumors (< or =2 cm) shows no significant difference in local recurrence or survival compared to lobectomy.
- These findings are particularly relevant for elderly patients and those with comorbidities making them high-risk for lobectomy.
Conclusions:
- Careful patient and tumor selection is crucial for optimizing surgical approach in early-stage NSCLC.
- Sublobar resection is a viable option for select patients with small tumors, while lobectomy remains standard for larger tumors or when margins are compromised.
- Ongoing randomized trials will further clarify the role of sublobar resection in early-stage NSCLC treatment.
